Evaluating the Effectiveness of a Chronic Disease Management Program for Gout

Completed · Not applicable

Conditions studied: Recurrent or Tophaceous Gout

In brief

The aim of this study is to test the effectiveness of a pharmacist-staffed, protocol-based chronic disease management program compared to patients receiving usual care in achieving a target serum uric acid level in patients with recurrent gout.

Key facts

Study ID

NCT01568879

Run by

Kaiser Permanente

People needed

104

Starts

2012-01-01

Expected to finish

2014-11-01

Last updated by the study team

2015-03-06

Who can join

Age: 21 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Three or more outpatient/ED visits in a 24-month period prior to selection for study with one of these primary visit diagnoses:
• Gouty arthropathy
• Gout, unspecified
• Gout with other specified manifestations
• Tophaceous gout of ear (274.81) or other sites
• Gouty nephropathy
• At least 2 years of continuous Kaiser Foundation Hospital Plan membership
• Baseline uric acid level above 7.0mg/dl

You may not qualify if…

• Current cancer diagnosis with active treatment
• End stage renal disease
• Pregnant or lactating
• Patients with a diagnosis of dementia
• Terminally ill patients

Where it is running

• Kaiser Permanente Northern California Medical Facilities — All KPNC Facilities, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.